Mark Alexander Skarsfeldt

Dr. Mark Alexander Skarsfeldt

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2018 in Scientific Reports
Verified
Journal Article
Open access
PDF file
JKJensen Kasper
Jensen Kasper
MSMark Alexander Skarsfeldt
Mark Alexander Skarsfeldt
HSHans Stærkind
Hans Stærkind
JAJens Arnbak
Jens Arnbak
Mikhail BalabasMikhail Balabas
Mikhail Balabas
EPEugene S. Polzik
Eugene S. Polzik
Optically pumped magnetometers are becoming a promising alternative to cryogenically-cooled superconducting magnetometers for detecting and imaging biomagnetic fields. Magnetic field detection is a completely non-invasive method, which allows one to study the function of excitable human organs with a sensor placed outside the human body. For instance, magnetometers can be used to detect brain activity or to study the activity of the heart. We have developed a highly sensitive miniature optically pumped magnetometer based on cesium atomic vapor kept in a paraffin-coated glass container. The magnetometer is optimized for detection of biological signals and has high temporal and spatial resolution. It is operated at room- or human body temperature and can be placed in contact with or at a mm-distance from a biological object. With this magnetometer, we detected the heartbeat of an isolated guinea-pig heart, which is an animal widely used in biomedical studies. In our recordings of the magnetocardiogram, we can detect the P-wave, QRS-complex and T-wave associated with the cardiac cycle in real time. We also demonstrate that our device is capable of measuring the cardiac electrographic intervals, such as the RR- and QT-interval, and detecting drug-induced prolongation of the QT-interval, which is important for medical diagnostics.

21 April 2015 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
SLSara I. Liin
Sara I. Liin
MEMalin Silverå Ejneby
Malin Silverå Ejneby
RBRene Barro-Soria
Rene Barro-Soria
MSMark Alexander Skarsfeldt
Mark Alexander Skarsfeldt
JLJohan E. Larsson
Johan E. Larsson
FEFredrik Elinder
Fredrik Elinder
Significance: More than 300 mutations in the genes encoding the cardiac I Ks channel have been identified in patients with cardiac arrhythmia. These mutations cause either loss of function or gain of function of the I Ks channel. This study describes how polyunsaturated fatty acids and their analogues activate or inhibit the I Ks channel. These modulators can restore rhythmic firing in arrhythmic firing cardiac myocytes and restore prolonged QT interval in guinea pig hearts. The study also describes a mechanism by which an auxiliary β-subunit alters the pharmacological sensitivity of the I Ks channel. Our findings may form the basis for future design of antiarrhythmic compounds that target I Ks channels for treating different cardiac arrhythmias caused by mutations in the I Ks channel.

10 March 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
MKMorten Asser Karsdal
Morten Asser Karsdal
TCThomas R. Cox
Thomas R. Cox
Amelia ParkerAmelia Parker
Amelia Parker
NWNicholas Willumsen
Nicholas Willumsen
JSJannie Marie Bülow Sand
Jannie Marie Bülow Sand
SRSylvie Ricard-Blum
Sylvie Ricard-Blum
The extracellular matrix (ECM) is the common denominator of more than 50 chronic diseases. Some of these chronic pathologies lead to enhanced tissue formation and deposition, whereas others are associated with increased tissue degradation, and some exhibit a combination of both, leading to severe tissue alterations. To develop effective therapies for diseases affecting the lung, liver, kidney, skin, intestine, musculoskeletal system, heart, and solid tumors, we need to modulate the ECM’s composition to restore its organization and function. Across diverse organ diseases, there are common denominators and distinguishing factors in this fibroinflammatory axis, which may be used to foster new insights into drug development across disease indications. The 2nd Extracellular Matrix Pharmacology Congress took place in Copenhagen, Denmark, from 17 to 19 June 2024 and was hosted by the International Society of Extracellular Matrix Pharmacology. The event was attended by 450 participants from 35 countries, among whom were prominent scientists who brought together state-of-the-art research on organ diseases and asked important questions to facilitate drug development. We highlight key aspects of the ECM in the liver, kidney, skin, intestine, musculoskeletal system, lungs, and solid tumors to advance our understanding of the ECM and its central targets in drug development. We also highlight key advances in the tools and technology that enable this drug development, thereby supporting the ECM.

5 January 2016 in Pflügers Archiv - European Journal of Physiology
Verified
Journal Article
Closed access
PDF file
MSMark Alexander Skarsfeldt
Mark Alexander Skarsfeldt
TJThomas A. Jepps
Thomas A. Jepps
SBSofia H. Bomholtz
Sofia H. Bomholtz
LALea Abildgaard
Lea Abildgaard
USUlrik S. Sørensen
Ulrik S. Sørensen
BBBo H. Bentzen
Bo H. Bentzen

11 April 2020 in Acta Physiologica
Verified
Journal Article
Closed access
PDF file
MSMark Alexander Skarsfeldt
Mark Alexander Skarsfeldt
SLSara I. Liin
Sara I. Liin
HLHans P. Larsson
Hans P. Larsson
BBBo Hjorth Bentzen
Bo Hjorth Bentzen

7 February 2018 in Acta Physiologica
Verified
Journal Article
Closed access
PDF file
MSMark Alexander Skarsfeldt
Mark Alexander Skarsfeldt
SBS. H. Bomholtz
S. H. Bomholtz
PLP. R. Lundegaard
P. R. Lundegaard
ALA. Lopez‐Izquierdo
A. Lopez‐Izquierdo
MTM. Tristani‐Firouzi
M. Tristani‐Firouzi
BBB. H. Bentzen
B. H. Bentzen